Oxymorphone Extended-Release Tablets and Sodium Phenylbutyrate Tablets
Determining the interaction of Oxymorphone Extended-Release Tablets and Sodium Phenylbutyrate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate, Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Oxymorphone Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Oxymorphone Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Oxymorphone Extended-Release Tablets-Sodium Phosphates
- Oxymorphone Extended-Release Tablets-Sodium Phosphates Enema
- Oxymorphone Extended-Release Tablets-Sodium Phosphates Injection
- Sodium Phenylbutyrate Tablets-Oxymorphone Hydrochloride
- Sodium Phenylbutyrate Tablets-Oxymorphone Injection
- Sodium Phenylbutyrate Tablets-Oxymorphone Tablets
- Sodium Phenylbutyrate Tablets-Oxytocin
- Sodium Phenylbutyrate Tablets-Oxytocin Intravenous, Intramuscular
- Sodium Phenylbutyrate Tablets-Oxytrol